HCA Healthcare (HCA)
(Delayed Data from NYSE)
$415.54 USD
+9.06 (2.23%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $415.66 +0.12 (0.03%) 5:08 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$415.54 USD
+9.06 (2.23%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $415.66 +0.12 (0.03%) 5:08 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Zacks News
Why Should You Add Magellan Health to Your Portfolio?
by Zacks Equity Research
Banking high on wise strategic measures and a favorable operating performance, Magellan Health (MGLN) can be added to your portfolio.
Top Research Reports for Adobe, Charter Communications & HCA Healthcare
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Adobe (ADBE), Charter Communications (CHTR) and HCA Healthcare (HCA).
Why it is Worth Betting on Cigna Stock for Your Portfolio
by Zacks Equity Research
Banking on prudent buyouts and solid overseas business, Cigna (CI) holds immense potential to reap benefits for investors.
MEDNAX Forges Alliance for Better Health Services in Texas
by Zacks Equity Research
MEDNAX (MD) collaborates with Alfredo Gei MD, P.A. to provide patients with better healthcare services in Houston.
Why Should You Hold Community Health in Your Portfolio?
by Zacks Equity Research
Riding high on its restructuring initiative and growth strategy, Community Health (CYH) holds immense potential to reap benefits for investors.
Trade Progress Fuels a Huge Relief Rally
by David Borun
Resolution of the thorny trade issues with Mexico bring about the best week of 2019 for US equities
Anthem (ANTM) Inks Deal to Acquire Beacon Health Options
by Zacks Equity Research
Anthem (ANTM) enters into an agreement to buy Beacon Health Options for enhancing health outcomes of patients.
Ensign Group (ENSG) on Buyout Spree to Enrich Portfolio
by Zacks Equity Research
Ensign Group (ENSG) purchases the assets of Preceptor Health Care and the real estate and operations of Golden Palms Rehabilitation and Retirement.
U.S. Service Sector Expands at a Brisk Pace: Top 5 Winners
by Tirthankar Chakraborty
The U.S. service sector grows faster in May defying slowdown in economic growth and rising trade tensions.
3 Reasons Why Growth Investors Shouldn't Overlook HCA (HCA)
by Zacks Equity Research
HCA (HCA) possesses solid growth attributes, which could help it handily outperform the market.
Universal Health's Segmental Strength Aids, High Costs Hurt
by Zacks Equity Research
Solid segmental contributions bode well for Universal Health's (UHS) growth. However, elevated expenses are a lingering concern.
Why Is HCA (HCA) Down 1.8% Since Last Earnings Report?
by Zacks Equity Research
HCA (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Should You Add WellCare Health (WCG) to Your Portfolio?
by Zacks Equity Research
Riding high on a solid revenue base and inorganic growth profile, WellCare Health (WCG) holds high potential to reap benefits for investors.
Why Adding HCA Healthcare to Your Portfolio Makes Sense
by Zacks Equity Research
Riding high on rising revenues and inorganic growth story, HCA Healthcare (HCA) looks promising enough to garner benefits for investors.
Here is Why Growth Investors Should Buy HCA (HCA) Now
by Zacks Equity Research
HCA (HCA) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Looking for Value? Why It Might Be Time to Try HCA Healthcare (HCA)
by Zacks Equity Research
HCA Healthcare (HCA) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
Hospital Industry Outlook: Demography, Consolidation Act As Tailwinds
by Sapna Bagaria
Hospital industry to gain from demographical changes and growing consolidation, partially offset by high labor cost.
Solid US Labor Market Puts Focus on 3 Sector ETFs & Stocks
by Sanghamitra Saha
The U.S. labor market has been in great shape defying slowdown worries. Unemployment rate fell to a fresh 49-year low in April. Play this optimism with these sector ETFs and stocks.
The Zacks Analyst Blog Highlights: Pfizer, Intel, HCA Healthcare, Xilinx and Cummins
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Pfizer, Intel, HCA Healthcare, Xilinx and Cummins
3 Reasons Growth Investors Will Love HCA (HCA)
by Zacks Equity Research
HCA (HCA) possesses solid growth attributes, which could help it handily outperform the market.
Top Stock Reports for Pfizer, Intel & HCA Healthcare
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Pfizer (PFE), Intel (INTC) and HCA Healthcare (HCA).
HCA Healthcare's (HCA) Q1 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) first-quarter earnings gain traction from higher revenues and better admissions.
HCA Healthcare (HCA) Q1 Earnings and Revenue Beat Estimates
by Zacks Equity Research
HCA Healthcare (HCA) first-quarter earnings gain from solid revenues.
What's in Store for HCA Healthcare's (HCA) Q1 Earnings?
by Zacks Equity Research
HCA Healthcare (HCA) is likely to gain from higher admissions. However, escalating expenses might weigh down its margins.
Earnings Preview: HCA Holdings (HCA) Q1 Earnings Expected to Decline
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.